| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 23.892 | 53.389 | 65.125 | 75.994 | 212.074 | 207.867 | 219.638 | 316.135 |
| Total Income - EUR | - | - | 23.892 | 53.389 | 65.126 | 75.995 | 221.390 | 207.868 | 240.614 | 323.715 |
| Total Expenses - EUR | - | - | 10.872 | 23.882 | 23.869 | 28.894 | 166.219 | 138.231 | 188.963 | 165.286 |
| Gross Profit/Loss - EUR | - | - | 13.019 | 29.508 | 41.257 | 47.101 | 55.171 | 69.637 | 51.651 | 158.429 |
| Net Profit/Loss - EUR | - | - | 12.778 | 28.973 | 40.606 | 46.554 | 53.570 | 67.601 | 49.289 | 148.885 |
| Employees | - | - | 2 | 2 | 2 | 2 | 7 | 6 | 5 | 4 |
Check the financial reports for the company - Diabmon Mar Life Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 192 | 709 | 630 | 43.816 | 137.488 | 121.605 | 68.802 | 182.990 |
| Current Assets | - | - | 14.111 | 44.001 | 42.159 | 35.430 | 34.187 | 81.196 | 33.601 | 126.266 |
| Inventories | - | - | 0 | 193 | 190 | 17.560 | 578 | 11 | 0 | 2.630 |
| Receivables | - | - | 2.635 | 2.685 | 4.536 | 42 | 5.408 | 65.080 | 14.494 | 100.522 |
| Cash | - | - | 11.475 | 41.122 | 37.433 | 17.828 | 28.202 | 16.105 | 19.106 | 23.114 |
| Shareholders Funds | - | - | 12.822 | 41.560 | 40.656 | 65.766 | 86.439 | 67.650 | 49.338 | 148.934 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.481 | 3.150 | 2.133 | 13.481 | 85.236 | 135.151 | 53.066 | 160.322 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diabmon Mar Life Srl